skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries
Material Type:
Article
Add to My Research

1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A262-A262 [Peer Reviewed Journal]

2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91114-X

Full text available

2
1061-88 Causes of death in patients with ST elevation myocardial infarction treated with fibrinolysis
Material Type:
Article
Add to My Research

1061-88 Causes of death in patients with ST elevation myocardial infarction treated with fibrinolysis

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A263-A263 [Peer Reviewed Journal]

2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91119-9

Full text available

3
1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes
Material Type:
Article
Add to My Research

1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A278-A278 [Peer Reviewed Journal]

2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91180-1

Full text available

4
2019 REVIEWERS FOR ENDOCRINE PRACTICE
Material Type:
Article
Add to My Research

2019 REVIEWERS FOR ENDOCRINE PRACTICE

Endocrine practice, 2020-01, Vol.26 (1), p.142-155 [Peer Reviewed Journal]

Copyright Allen Press Publishing Services Jan 2020 ;ISSN: 1530-891X ;EISSN: 1934-2403 ;DOI: 10.4158/1934-2403-26.1.142 ;PMID: 32022601

Full text available

5
883-2 The association of race with angiographic and clinical outcomes following fibrinolytic administration
Material Type:
Article
Add to My Research

883-2 The association of race with angiographic and clinical outcomes following fibrinolytic administration

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A305-A305 [Peer Reviewed Journal]

2004 ;Copyright Elsevier Limited Mar 3, 2004 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(04)91289-2

Full text available

6
Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
Material Type:
Article
Add to My Research

Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial

Circulation (New York, N.Y.), 1999-06, Vol.99 (21), p.2720-2732 [Peer Reviewed Journal]

1999 INIST-CNRS ;Copyright American Heart Association, Inc. Jun 1, 1999 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/01.CIR.99.21.2720 ;CODEN: CIRCAZ

Full text available

7
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction : Observations from the TIMI 14 trial
Material Type:
Article
Add to My Research

Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction : Observations from the TIMI 14 trial

Circulation (New York, N.Y.), 2000-01, Vol.101 (3), p.239-243 [Peer Reviewed Journal]

2000 INIST-CNRS ;Copyright American Heart Association, Inc. Jan 25, 2000 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/01.CIR.101.3.239 ;PMID: 10645918 ;CODEN: CIRCAZ

Full text available

8
Abstract 11043: Clinical Safety Outcomes in Relation to Lipoprotein(a) Concentration: Insights from the FOURIER Trial
Material Type:
Article
Add to My Research

Abstract 11043: Clinical Safety Outcomes in Relation to Lipoprotein(a) Concentration: Insights from the FOURIER Trial

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1) [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.144.suppl_1.11043

Full text available

9
Abstract 11524: Ezetimibe Consistently Reduces LDL-C with Little Interindividual Variability in 14,970 Patients Post-ACS
Material Type:
Article
Add to My Research

Abstract 11524: Ezetimibe Consistently Reduces LDL-C with Little Interindividual Variability in 14,970 Patients Post-ACS

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1) [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.144.suppl_1.11524

Full text available

10
Abstract 11748: Edoxaban versus Warfarin in Patients at Increased Risk of Falling - A Subgroup Analysis of the ENGAGE AF-TIMI 48 Trial
Material Type:
Article
Add to My Research

Abstract 11748: Edoxaban versus Warfarin in Patients at Increased Risk of Falling - A Subgroup Analysis of the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A11748-A11748

2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539

Full text available

11
Abstract 11753: Outcomes in Women vs. Men After Non-ST-Elevation Acute Coronary Syndromes: Insights From the TIMI Trials
Material Type:
Article
Add to My Research

Abstract 11753: Outcomes in Women vs. Men After Non-ST-Elevation Acute Coronary Syndromes: Insights From the TIMI Trials

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A11753-A11753

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539

Full text available

12
Abstract 12195: Relationship Between Transcatheter Aortic Valve Replacement Wait Time and Mortality in Patients With Symptomatic Severe Aortic Stenosis
Material Type:
Article
Add to My Research

Abstract 12195: Relationship Between Transcatheter Aortic Valve Replacement Wait Time and Mortality in Patients With Symptomatic Severe Aortic Stenosis

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A12195-A12195

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539

Full text available

13
Abstract 12361: Efficacy and Safety of NOACs vs. Warfarin Across the Continuous Range of Body Mass Index and Body Weight: Insights From COMBINE-AF
Material Type:
Article
Add to My Research

Abstract 12361: Efficacy and Safety of NOACs vs. Warfarin Across the Continuous Range of Body Mass Index and Body Weight: Insights From COMBINE-AF

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1) [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.146.suppl_1.12361

Full text available

14
Abstract 12680: Efficacy and Safety of Edoxaban Compared With Warfarin in Patients With Atrial Fibrillation and Heart Failure: Insights From Engage-AF TIMI 48
Material Type:
Article
Add to My Research

Abstract 12680: Efficacy and Safety of Edoxaban Compared With Warfarin in Patients With Atrial Fibrillation and Heart Failure: Insights From Engage-AF TIMI 48

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2) [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.130.suppl_2.12680

Full text available

15
Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial
Material Type:
Article
Add to My Research

Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A13035-A13035

2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539

Full text available

16
Abstract 13200: Relationship Between Baseline Low-Density Lipoprotein Cholesterol and Percent Low-Density Lipoprotein Cholesterol Reduction With Evolocumab in the FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk) Trial
Material Type:
Article
Add to My Research

Abstract 13200: Relationship Between Baseline Low-Density Lipoprotein Cholesterol and Percent Low-Density Lipoprotein Cholesterol Reduction With Evolocumab in the FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk) Trial

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13200-A13200 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.142.suppl_3.13200

Full text available

17
Abstract 13702: A Novel Genetic Risk Score Predicts Ischemic Stroke in Patients With Cardiometabolic Disease
Material Type:
Article
Add to My Research

Abstract 13702: A Novel Genetic Risk Score Predicts Ischemic Stroke in Patients With Cardiometabolic Disease

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13702-A13702 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.142.suppl_3.13702

Full text available

18
Abstract 13833: Impact of Lowering LDL-C With Evolocumab on Everyday Cognition in Participants From the FOURIER Trial
Material Type:
Article
Add to My Research

Abstract 13833: Impact of Lowering LDL-C With Evolocumab on Everyday Cognition in Participants From the FOURIER Trial

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A13833-A13833

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.140.suppl_1.13833

Full text available

19
Abstract 13871: Evolocumab and Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: Analysis From FOURIER
Material Type:
Article
Add to My Research

Abstract 13871: Evolocumab and Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: Analysis From FOURIER

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A13871-A13871

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.140.suppl_1.13871

Full text available

20
Abstract 14083: Prognostic Significance of Left Ventricular Systolic Dysfunction at the Time of NSTEMI in Patients With No Prior History of Heart Failure
Material Type:
Article
Add to My Research

Abstract 14083: Prognostic Significance of Left Ventricular Systolic Dysfunction at the Time of NSTEMI in Patients With No Prior History of Heart Failure

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A14083-A14083

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circ.140.suppl_1.14083

Full text available

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (461)

Refine My Results

Creation Date 

From To
  1. Before 2000  (17)
  2. 2000 To 2005  (83)
  3. 2006 To 2011  (58)
  4. 2012 To 2018  (200)
  5. After 2018  (134)
  6. More options open sub menu

Language 

  1. English  (490)
  2. Japanese  (36)
  3. Portuguese  (2)
  4. Russian  (2)
  5. Norwegian  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait